Stock·NASDAQ·Healthcare
Capricor Therapeutics, Inc. (CAPR)
- Market cap
- $333.72M
- Dividend yield
- None
- Street target
- $25.00median of 10 analysts
- 52-week range
- $2.96 $40.37
CAPR stock forecast today
Where CAPR stands today, and what CleaRank Financial AI makes of it.
CAPR at a glance
Capricor Therapeutics, Inc. (CAPR): Sell, 24/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($8.14 and $21.04).
- Earnings CAPR has not beaten estimates in any of the 5 reports in our data.
- Insiders Insiders sold $7.6M and made no open-market purchases over the last 18 months.
Figures as of October 26, 2026.
CleaRank Financial AI
CleaRank rates Capricor Therapeutics, Inc. (CAPR) Sell, with a model score of 24/100.
The analysts' outlook lifts the score most: the median target is 335.5% above the price. The trend holds it back most: the price is 72.72% below its 200-day average and 29.45% below its 50-day average, and the 50-day average is 61.32% below the 200-day. The 50-day average stands at $8.14 and the 200-day at $21.04. Over the past year the price fell 7.42%.
Only on CleaRank
Figures we compute ourselves from CAPR's own price, earnings and insider-filing history. Tap one to see it in context.
CAPR stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $5.74 is 29.5% below the 50-day simple moving average of $8.14.Price above its 200-day average ›
The price is 72.7% below the 200-day simple moving average of $21.04.50-day average above the 200-day ›
The 50-day average ($8.14) is 61.3% below the 200-day average ($21.04), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 7% of its 52-week range, between $2.96 and $40.37.
CAPR share price
Pick a period: each tab shows how far CAPR has moved over it, to the last close.
Today's trading
Where CAPR sits inside today's range and its 52-week range.
CAPR fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
0/1Beat estimates in most recent reports ›
CAPR beat the EPS estimate in 0 of the 5 reports in our data.
Key statistics
The headline figures for CAPR.
As of October 26, 2026, CAPR trades at $5.74, with a market value of $333.72M and no P/E ratio (its trailing earnings are negative).
What the numbers say
CleaRank Financial AI's reading of CAPR's valuation, growth and risks.
Capricor Therapeutics, Inc. (CAPR) has no usable P/E, since its earnings per share over the last 12 months are negative, making the ratio not meaningful. Its trailing earnings stand at -$2.45 a share.
Its return on equity of -73.70% sits below the sector median of 7.3%. Debt-to-equity of 0.37 completes the financial picture.
CAPR's latest quarterly report, released on August 13, 2026, showed EPS of -$0.70 against an estimate of -$0.58, which was worse than analysts had expected. Yet the stock moved the other way, climbing 57.96% in the session that followed.
Across the 5 reports in our data, CAPR has never beaten the EPS estimate. Analysts expect EPS of -$1.45 for this fiscal year and -$1.45 for the next.
CAPR typically moves 5.72% on a given day, based on the 30-day standard deviation of its daily returns, and its beta against the S&P 500 is 0.61. The trend will keep working against holders until the price climbs back above its moving averages. The stock is 85.78% below its 52-week high of $40.37. Over the last 18 months insiders sold $7.6M of stock and made no open-market purchases. Such sales are frequently planned ahead, so they carry less weight than buying would.
CAPR against the Healthcare sector
How CAPR compares with the median Healthcare stock CleaRank tracks.
Return vs XLV: Since May 14, 2025, CAPR has lost 25.2% against a gain of 39.2% for XLV.
Performance against XLV
CAPR and the Healthcare sector fund over the same days.
Revenue and earnings
How much CAPR sells, and how much of it becomes profit.
Revenue growth: Revenue fell 11.5% in FY2024 to $22.3M, from $25.2M a year earlier.
Profit margin: The net margin was -181.7% in FY2024, down from -88.5% the year before.
Loss-making: CAPR lost $40.5M in FY2024.
Earnings reality check
Did CAPR beat what analysts expected, and how did the stock react?
Earnings record: CAPR did not beat the analyst estimate in the 5 reports in our data.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 13, 2026after close | -$0.58 | -$0.70 | -20.69% | +57.96% | +62.47% |
| Nov 10, 2025after close | -$0.54 | -$0.54 | +0.00% | +11.51% | +2.34% |
| Aug 11, 2025after close | -$0.48 | -$0.57 | -18.75% | +2.81% | -1.53% |
| May 13, 2025after close | -$0.32 | -$0.53 | -65.63% | +5.07% | +50.82% |
| Nov 13, 2024after close | -$0.34 | -$0.38 | -11.76% | +9.34% | +11.89% |
As of October 26, 2026, CAPR has beaten the analyst EPS estimate in 0 of the 5 reports in our data; its latest report, on August 13, 2026, came in 20.69% below the estimate and the stock moved +57.96% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
CAPR AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 32.5, showing bearish momentum without being oversold.RSI above 50 ›
An RSI of 32.5 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of CAPR
The score, the reasoning behind it, and what could move the price next.
Capricor Therapeutics, Inc. (CAPR) is in a downtrend. At $5.74 the stock sits 72.72% below its 200-day average of $21.04 and 29.45% below its 50-day average of $8.14. Near the bottom of its 52-week range, the price is 93.92% above the low of $2.96, yet 85.78% below the high of $40.37. Both averages point the same way, since the 50-day sits 61.32% below the 200-day.
The 14-day RSI of 32.5 is in the bearish zone, above the oversold line, and the MACD line is negative. The recent returns are all negative: the price fell 18.00% over the past three months, fell 83.65% over the past six months and fell 7.42% over the past year. Volume in the last session ran 34.9% below its average, on a day the price fell 3.20%.
Analyst upgrade ›
B. Riley Securities upgraded it to Buy from Neutral on September 14, 2026.
Source: Analyst action, B. Riley Securities, September 14, 2026Analyst upgrade ›
Piper Sandler upgraded it to Overweight from Neutral on September 1, 2026.
Source: Analyst action, Piper Sandler, September 1, 2026
Earnings miss, but the stock rose ›
The August 13, 2026 report missed the EPS estimate by 20.69%, and the share price rose 57.96% in the first session after it.
Source: Earnings report, August 13, 2026
- The two nearest levels to watch are the 20-day EMA at $7.08, above the price, and the 52-week low at $2.96, below it.
- A 14-day RSI of 32.5 falls in the bearish zone, and the MACD line is negative. Stretched momentum shows up as readings above 70 or below 30.
- CAPR rose 57.96% in the first session after its August 13, 2026 report, but it has beaten estimates in 0 of the 5 reports in our data.
CAPR sits beneath both its 50-day ($8.14) and 200-day ($21.04) averages, and that placement is why the trend reads as down. A recovery would first need to reclaim the 50-day average. The closest level overhead is the 20-day EMA, at $7.08.
The 52-week low at $2.96 is the next level below. Momentum, with the RSI in the bearish zone, still points lower.
Technical indicators
Momentum and trend for CAPR, from its daily closes.
As of October 26, 2026, with CAPR at $5.74, its 14-day RSI is 32.5 (showing bearish momentum without being oversold), its 50-day simple moving average is $8.14 and its 200-day is $21.04.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What CAPR moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, CAPR's 1-year correlation of daily returns is +0.10 with S&P 500 (SPY), +0.09 with Nasdaq 100 (QQQ), +0.00 with Bitcoin (BTC) and -0.04 with gold (XAU).
CAPR price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
4 of 10 analysts rate it a buy or strong buy, 6 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $25.00 is 335.5% above the price.More buy ratings than three months ago ›
4 of 10 rate it a buy now, against 0 of 10 three months ago.
CAPR Wall Street View
12-month price targets
The price, $5.74, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 14, 2026 | B. Riley Securities | Upgrade | Buy |
| Sep 1, 2026 | Piper Sandler | Upgrade | Overweight |
| Aug 14, 2026 | Cantor Fitzgerald | Upgrade | Overweight |
| Jul 31, 2026 | Jones Trading | Downgrade | Hold |
| Jul 30, 2026 | Piper Sandler | Downgrade | Neutral |
| Jul 30, 2026 | Cantor Fitzgerald | Downgrade | Neutral |
As of October 26, 2026, 10 Wall Street analysts cover CAPR: 4 rate it a buy or strong buy, 6 a hold and 0 a sell or strong sell. Their 12-month price targets range from $7.00 to $54.00. The median CAPR price target is $25.00, 335.5% above the price of $5.74.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
CAPR trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
CAPR trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Short entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
CAPR moves about 5.7% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much CAPR tends to move, against the market and on its own.
CAPR price history and drawdowns
CAPR's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 5.72% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 97.1%, from March 2017 to March 2020, regained by March 2026.Most 1-year holds ended higher ›
53% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $1,834, against $42,015 in the S&P 500 (SPY).
CAPR Drawdowns & Recovery
As of October 26, 2026, CAPR's worst peak-to-trough fall over the last 10 years with dividends reinvested was -97.1% (March 2017 to March 2020); it regained that peak by March 2026, 72 months after the low, and 53% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into CAPR in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: CAPR trailed the S&P 500 over this period: $1,833.87 against $42,015.
A $10,000 investment in CAPR in October 2016 would be worth about $1,834 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to CAPR, and which have not.
Strongest month, April: an average of +57.72%, up in 4 of 10 years.
Weakest month, May: an average of -15.88%, up in 4 of 10 years.
This month, October: has averaged -4.26%, up in 2 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, CAPR's strongest calendar month has been April (average +57.72%, up in 4 of 10 years) and its weakest May (average -15.88%, up in 4 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
CAPR stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in CAPR, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in CAPR today could grow to about $7,910 by 2030 in the base case, with a 90th-percentile outcome near $28,496 and a 10th-percentile outcome around $2,196. Projections are statistical simulations, not guarantees.
CAPR Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $4.54 for CAPR by 2030 in the base case, from $5.74 today (0.8x over 4 years). The 10th-percentile path ends near $1.26. These are outcomes of a Monte Carlo simulation run on CAPR's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $2.85 | $5.41 | $10.27 | |
| 2028 | $2.06 | $5.11 | $12.64 | |
| 2029 | $1.59 | $4.81 | $14.61 | |
| 2030 | $1.26 | $4.54 | $16.36 |
Method: a lognormal simulation of CAPR's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
CAPR insider trading
What the people running the company have bought and sold.
CAPR insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought CAPR shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 26, 2026, CAPR insiders reported 8 open-market sales worth $7.6M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 25, 2026 | Anthony Bergmann
Chief Financial Officer
|
Sell | 24.1K | $732.2K |
| Jun 25, 2026 | Anthony Bergmann
Chief Financial Officer
|
Option | 24.1K | $76.6K |
| Jun 25, 2026 | Karen Krasney
General Counsel
|
Option | 24.1K | $76.6K |
| Jun 24, 2026 | Anthony Bergmann
Chief Financial Officer
|
Sell | 900 | $27.0K |
| Jun 24, 2026 | Anthony Bergmann
Chief Financial Officer
|
Option | 900 | $2.9K |
| Jun 24, 2026 | Karen Krasney
General Counsel
|
Option | 900 | $2.9K |
| May 18, 2026 | Anthony Bergmann
Chief Financial Officer
|
Option | 3.0K | $4.2K |
| May 13, 2026 | Frank I Litvack
Director
|
Option | 3.9K | $5.5K |
| May 1, 2026 | Karen Krasney
General Counsel
|
Sell | 25.0K | $792.5K |
| May 1, 2026 | Anthony Bergmann
Chief Financial Officer
|
Sell | 25.0K | $792.5K |
| May 1, 2026 | Anthony Bergmann
Chief Financial Officer
|
Option | 25.0K | $79.5K |
| May 1, 2026 | Karen Krasney
General Counsel
|
Option | 25.0K | $79.5K |
| Apr 2, 2026 | Karimah Es Sabar
Director
|
Sell | 7.5K | $240.9K |
| Apr 2, 2026 | Karimah Es Sabar
Director
|
Option | 7.5K | $23.9K |
| Apr 1, 2026 | Karimah Es Sabar
Director
|
Sell | 115.0K | $3.5M |
| Apr 1, 2026 | Karimah Es Sabar
Director
|
Option | 115.0K | $558.9K |
| Mar 31, 2026 | Anthony Bergmann
Chief Financial Officer
|
Sell | 25.0K | $753.2K |
| Mar 31, 2026 | Karen Krasney
General Counsel
|
Sell | 25.0K | $752.9K |
| Mar 31, 2026 | Anthony Bergmann
Chief Financial Officer
|
Option | 25.0K | $79.5K |
| Mar 31, 2026 | Karen Krasney
General Counsel
|
Option | 25.0K | $90.3K |
| Dec 30, 2025 | Karen Krasney
General Counsel
|
Option | 2.5K | $3.5K |
| Dec 19, 2025 | George W Dunbar Jr
Director
|
Option | 3.0K | $4.2K |
Source: TwelveData, from SEC Form 4 filings
CAPR stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.